MDcardionur retweetledi

Potent P2Y12 inhibitors, such as prasugrel and ticagrelor, are increasingly used in CCS patients undergoing PCI. In this study, there were no differences between potent P2Y12 inhibitors and clopidogrel in terms of ischemic and bleeding events at one year. ow.ly/rwRn50MvR7Q

English

























